• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TFGT-21A
Device Problems Backflow (1064); Material Split, Cut or Torn (4008)
Patient Problems Dyspnea (1816); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 07/14/2021
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
It was reported that on (b)(6) 2018, a 21mm trifecta gt valve was implanted.On an unknown date, the patient presented with aortic insufficiency; it was reported that the patient "heard a pop and then was short of breath." on (b)(6) 2021, the trifecta gt valve was explanted and upon explant, a torn leaflet was observed.A non-abbott valve was successfully implanted.The patient was reported to be recovering.No additional information is available.
 
Manufacturer Narrative
Additional information sections: d9, h3, h6, h10.Explant was reported due to aortic insufficiency and "the patient heard a pop and then was short of breath".The investigation found that all three leaflets were torn.Leaflet 1 had focal thin fibrous pannus on the inflow surface.Leaflet 1 and leaflet 2 had a thin layer of fibrin.There was no acute inflammation or significant calcifications.X-ray inspection of the returned valve demonstrated deformation of stent posts 2 and 3, which appeared bent outward.As this was an explanted valve it is not possible to confirm when the observed deformation occurred, or if the stent deformations contributed to the severity of the leaflet damage.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.This review was inclusive of the final inspection videos.The manufacturing inspections and the functional testing demonstrated that at the time the valve was manufactured the valve had normal leaflet coaptation and function without evidence of stent deformation.In the absence of any calcification or evidence for infection, the reported event is consistent with a non-calcific leaflet tear.Non-calcific leaflet tear is a form of structural valve deterioration (svd), which is a well-known complication from valve replacement surgery.A non-calcific leaflet tear is commonly attributed to increased operational leaflet stress but may also be related to biological factors which result in tissue degeneration characterized by loss of collagen.In this case, histological evaluation did demonstrate loss of collagen at the tear site, which could have contributed to the formation of the tear.The fibrous pannus ingrowth noted had the potential to induce increased stress on adjacent leaflets and create an unbalanced stress relief distribution between all leaflets during coaptation, leading to leaflet tears and reduced durability.There was also evidence of two outwardly bent stent post in association with the torn leaflets.An outward bent stent post may result in a localized increase in leaflet stress which may potentially contribute to the observed non-calcific leaflet tear.However, since it is unknown whether the stent deformation occurred before or after the valve explant, the cause of the torn leaflets cannot be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA¿ GT VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS  01897-4050
Manufacturer (Section G)
ST. JUDE MEDICAL, COSTA RICA LTDA (SH)
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS   01897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key12277174
MDR Text Key265055729
Report Number3014918977-2021-00037
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05415067018212
UDI-Public05415067018212
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/04/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/14/2021
Device Model NumberTFGT-21A
Device Catalogue NumberTFGT-21A
Device Lot NumberBR00014014
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/27/2021
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received11/29/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/16/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age67 YR
Patient SexFemale
-
-